Skip to content
Veracy Advisory Platform
← All tools

Geneious

Bioinformatics software platform for sequence analysis, molecular biology, and genomics research with AI-assisted annotation.

Listed Needs re-verification
Genomics $$ Mid-market Enterprise Life Sciences Healthcare

What it does

Geneious (by Dotmatics) is a bioinformatics software platform used by molecular biologists, geneticists, and genomics researchers for DNA and protein sequence analysis, phylogenetics, primer design, and molecular cloning. AI capabilities include AI-assisted sequence annotation that predicts gene features and functional elements from sequence data, ML-powered variant calling that identifies mutations in sequencing data with improved sensitivity over traditional methods, automated primer design that generates optimal PCR primers for any target sequence, intelligent sequence assembly that reconstructs genomes from sequencing reads, and AI-powered antibody sequence analysis for therapeutic antibody development programs.

Strengths

  • Pharmaceutical discovery teams and academic research labs use Geneious for molecular biology data analysis - AI sequence analysis reducing bioinformatics bottlenecks in drug discovery workflows.
  • Large pharmaceutical companies and genomics companies use Geneious for enterprise bioinformatics - AI-assisted analysis across large genomic datasets and antibody analysis supporting therapeutic development programs.
  • Geneious (by Dotmatics) is a bioinformatics software platform used by molecular biologists, geneticists, and genomics researchers for DNA and protein sequence analysis, phylogenetics, primer design, and molecular cloning.

Watch-outs

  • Bioinformatics and molecular biology focus only: Geneious is purpose-built for biological sequence analysis — non-biology research, clinical genomics patient care, and other life sciences applications have different tooling requirements.
  • Computational biology expertise required: Geneious's AI tools accelerate expert bioinformatics work — researchers without molecular biology and bioinformatics training cannot productively use the platform's analytical capabilities independently.
  • Dotmatics acquisition creates portfolio integration questions: Geneious is part of Dotmatics' R&D software portfolio — buyers should assess product roadmap continuity and integration with Dotmatics' broader scientific data platform.

Pricing

Geneious Prime from $1,540/user/year. Research licenses for academic use at lower rates. Enterprise team pricing negotiated. Annual contracts.